Andover, MA – According to filings with the U.S. Securities and Exchange Commission, AI Proteins is raising $18,205,000.00 in new funding. Sources indicate as part of senior management Co-Founder, Chris Bahl played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AI Proteins
AI Proteins is a newly founded biotechnology company focused on the design and engineering of synthetic miniprotein therapeutics. We combine cutting-edge computational protein design with advanced laboratory robotics to accelerate the creation of life-changing medicines. Our common goal is to markedly improve human health and wellbeing. Our environment is rigorous, fast-paced and collaborative, bringing together passionate individuals who are making an impact. We inspire creativity and discovery by embracing an open culture that fosters innovation, initiative, teamwork and excellence.

To learn more about AI Proteins, visit http://www.aiproteins.design/

Contact:
Chris Bahl, Co-Founder
617-412-6117
https://www.linkedin.com/in/cdbahl/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved